308 related articles for article (PubMed ID: 20846699)
1. Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis.
Casanova-Esteban P; Guiral N; Andrés E; Gonzalvo C; Mateo-Gallego R; Giraldo P; Paramo JA; Civeira F
Metabolism; 2011 Jun; 60(6):830-4. PubMed ID: 20846699
[TBL] [Abstract][Full Text] [Related]
2. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
[TBL] [Abstract][Full Text] [Related]
3. Glucose metabolism after normalization of markers of iron overload by venesection in subjects with hereditary hemochromatosis.
Hatunic M; Finucane FM; Norris S; Pacini G; Nolan JJ
Metabolism; 2010 Dec; 59(12):1811-5. PubMed ID: 20673928
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of phlebotomy to reduce transfusional iron overload in adult, long-term survivors of acute leukemia.
Franchini M; Gandini G; Veneri D; de Matteis G; Federici F; Solero P; Aprili G
Transfusion; 2004 Jun; 44(6):833-7. PubMed ID: 15157247
[TBL] [Abstract][Full Text] [Related]
5. Hepatic iron concentration in hereditary hemochromatosis does not saturate or accurately predict phlebotomy requirements.
Olynyk JK; Luxon BA; Britton RS; Bacon BR
Am J Gastroenterol; 1998 Mar; 93(3):346-50. PubMed ID: 9517637
[TBL] [Abstract][Full Text] [Related]
6. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
Pedersen P; Milman N
Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
[TBL] [Abstract][Full Text] [Related]
7. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis.
Hicken BL; Tucker DC; Barton JC
Am J Gastroenterol; 2003 Sep; 98(9):2072-7. PubMed ID: 14499790
[TBL] [Abstract][Full Text] [Related]
8. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.
Valenti L; Fracanzani AL; Dongiovanni P; Bugianesi E; Marchesini G; Manzini P; Vanni E; Fargion S
Am J Gastroenterol; 2007 Jun; 102(6):1251-8. PubMed ID: 17391316
[TBL] [Abstract][Full Text] [Related]
9. H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload?
de Diego C; Opazo S; Murga MJ; Martínez-Castro P
Eur J Haematol; 2007 Jan; 78(1):66-71. PubMed ID: 17042772
[TBL] [Abstract][Full Text] [Related]
10. Mutations in HFE causing hemochromatosis are associated with primary hypertriglyceridemia.
Solanas-Barca M; Mateo-Gallego R; Calmarza P; Jarauta E; Bea AM; Cenarro A; Civeira F
J Clin Endocrinol Metab; 2009 Nov; 94(11):4391-7. PubMed ID: 19820015
[TBL] [Abstract][Full Text] [Related]
11. [Iron storage disease].
Horváth G; Dávid K
Orv Hetil; 2004 Sep; 145(39):1979-84. PubMed ID: 15553908
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic erythrocytapheresis versus phlebotomy in the initial treatment of hereditary hemochromatosis - A pilot study.
Rombout-Sestrienkova E; van Noord PA; van Deursen CT; Sybesma BJ; Nillesen-Meertens AE; Koek GH
Transfus Apher Sci; 2007 Jun; 36(3):261-7. PubMed ID: 17569592
[TBL] [Abstract][Full Text] [Related]
13. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
Kowdley KV; Brandhagen DJ; Gish RG; Bass NM; Weinstein J; Schilsky ML; Fontana RJ; McCashland T; Cotler SJ; Bacon BR; Keeffe EB; Gordon F; Polissar N;
Gastroenterology; 2005 Aug; 129(2):494-503. PubMed ID: 16083706
[TBL] [Abstract][Full Text] [Related]
14. Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with HFE-related hemochromatosis: a case-control study.
Kom GD; Schwedhelm E; Nielsen P; Böger RH
Free Radic Biol Med; 2006 Apr; 40(7):1194-200. PubMed ID: 16545687
[TBL] [Abstract][Full Text] [Related]
15. [Hereditary hemocromatosis].
Franchini M; Veneri D
Recenti Prog Med; 2004 Oct; 95(10):457-62. PubMed ID: 15560291
[TBL] [Abstract][Full Text] [Related]
16. [Hemochromatosis--from an underdiagnosed curiosity to a common disease].
Hagve TA; Asberg A; Ulvik R; Borch-Iohnsen B; Thorstensen K
Tidsskr Nor Laegeforen; 2009 Apr; 129(9):863-6. PubMed ID: 19415085
[TBL] [Abstract][Full Text] [Related]
17. Hereditary hemochromatosis: laboratory evaluation.
Moyer TP; Highsmith WE; Smyrk TC; Gross JB
Clin Chim Acta; 2011 Aug; 412(17-18):1485-92. PubMed ID: 21510925
[TBL] [Abstract][Full Text] [Related]
18. Soluble transferrin receptor in hemochromatosis patients during phlebotomy therapy.
Piéroni L; Mekhloufi F; Thiolières JM; Hainque B; Herson S; Jardel C
Clin Chim Acta; 2005 Mar; 353(1-2):61-6. PubMed ID: 15698591
[TBL] [Abstract][Full Text] [Related]
19. H63D mutation in the HFE gene increases iron overload in beta-thalassemia carriers.
Melis MA; Cau M; Deidda F; Barella S; Cao A; Galanello R
Haematologica; 2002 Mar; 87(3):242-5. PubMed ID: 11869934
[TBL] [Abstract][Full Text] [Related]
20. Hereditary hemochromatosis.
Franchini M; Veneri D
Hematology; 2005 Apr; 10(2):145-9. PubMed ID: 16019461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]